INmune Bio Ownership | Who Owns INmune Bio?

Overview Forecast RevenueFinancials Chart Transcripts

INmune Bio Ownership Summary

INmune Bio is owned by 24.10% institutional investors, 24.61% insiders, and 51.29% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 5.03% of INMB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 1.91% of its assets in INmune Bio shares.

INMB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	INmune Bio	24.10%	24.61%	51.29%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	1.17M	5.03%	$2.71M
Blackrock	812.89K	4.51%	$7.17M
Vanguard group	738.20K	3.66%	$3.45M
Cvi	596.37K	3.31%	$5.26M
Geode capital management	363.60K	1.80%	$1.70M
Millennium management	291.33K	1.44%	$1.36M
Raymond james financial	333.48K	1.43%	$770.33K
Raymond james financial services advisors	227.53K	1.26%	$2.01M
State street	226.43K	1.12%	$1.06M
Renaissance	185.80K	0.92%	$867.69K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cvi	596.37K	4.54%	$5.26M
Rhenman & partners asset management ab	178.28K	0.05%	$411.84K
Scientech research	45.74K	0.03%	$105.65K
Oxford asset management llp	22.49K	0.02%	$51.95K
Xtx topco	125.85K	0.01%	$290.71K
Laird norton trust company	37.00K	0.01%	$85.47K
Westside investment management	21.38K	0.01%	$49.38K
Atom investors lp	22.54K	0.00%	$52.07K
Financial advocates investment management	15.50K	0.00%	$72.39K
Gts securities	35.63K	0.00%	$82.30K

Top Buyers

Holder	Shares	% Assets	Change
Cvi	596.37K	4.54%	596.37K
Blackrock	812.89K	0.00%	572.73K
Raymond james financial services advisors	227.53K	0.00%	227.53K
Blackrock funding, inc. /de	1.17M	0.00%	224.08K
Ubs group	136.25K	0.00%	93.09K

Top Sellers

Holder	Shares	% Assets	Change
Praetorian pr	-	-	-865.00K
Pekin hardy strauss	-	-	-94.30K
Corton capital	-	-	-76.14K
Westside investment management	21.38K	0.01%	-67.83K
Heights capital management	-	-	-60.98K

New Positions

Holder	Shares	% Assets	Change	Value
Cvi	596.37K	4.54%	596.37K	$5.26M
Raymond james financial services advisors	227.53K	0.00%	227.53K	$2.01M
Scientech research	45.74K	0.03%	45.74K	$105.65K
Gts securities	35.63K	0.00%	35.63K	$82.30K
Atom investors lp	22.54K	0.00%	22.54K	$52.07K

Sold Out

Holder	Change
Eversource wealth advisors	-9.00
Gamma investing	-44.00
Fny investment advisers	-100.00
Thurston, springer, miller, herd & titak	-106.00
Coldstream capital management	-145.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	95	10.47%	5,614,076	-5.01%	24	3.49%	59	47.50%	14	-39.13%
Mar 31, 2025	87	16.00%	5,927,552	-3.93%	26	2.82%	41	-14.58%	23	228.57%
Dec 31, 2024	74	8.82%	6,168,914	15.26%	30	4.35%	48	4.35%	7	-12.50%
Sep 30, 2024	65	8.33%	5,259,609	15.17%	26	4.06%	44	22.22%	8	-20.00%
Jun 30, 2024	60	11.11%	4,566,933	66.72%	25	10.88%	36	33.33%	10	-16.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	434.27K	1.91%	-
Vanguard Total Stock Mkt Idx Inv	479.04K	1.80%	-10.47K
iShares Russell 2000 ETF	406.63K	1.53%	-
Rhenman Healthcare Equity L/S RC2 SEK	178.28K	0.67%	-
Fidelity Small Cap Index	168.80K	0.63%	28.59K
Bridge Builder Tax Managed Sm/Md Cp	164.97K	0.61%	164.97K
Vanguard Institutional Extnd Mkt Idx Tr	150.66K	0.57%	-68.65K
iShares Russell 2000 Growth ETF	145.86K	0.55%	-
Fidelity Extended Market Index	84.32K	0.32%	1.70K
Vanguard Russell 2000 ETF	78.87K	0.30%	-6.09K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 30, 2024	Moss David J	Chief Financial Officer	Buy	$52.87K
Sep 12, 2024	Tesi Raymond Joseph	President and CEO	Buy	$98.43K
Sep 12, 2024	Tesi Raymond Joseph	President and CEO	Buy	$98.05K
Sep 12, 2024	Moss David J	Chief Financial Officer	Buy	$49.22K
Sep 12, 2024	Moss David J	Chief Financial Officer	Buy	$49.02K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	5	-
2024 Q2	9	-
2023 Q4	1	-
2023 Q3	-	1
2023 Q1	1	-

INMB Ownership FAQ

Who Owns INmune Bio?

INmune Bio shareholders are primarily institutional investors at 24.10%, followed by 24.61% insiders and 51.29% retail investors. The average institutional ownership in INmune Bio's industry, Biotech Stocks , is 307.10%, which INmune Bio falls below.

Who owns the most shares of INmune Bio?

INmune Bio’s largest shareholders are Blackrock funding, inc. /de (1.17M shares, 5.03%), Blackrock (812.9K shares, 4.51%), and Vanguard group (738.2K shares, 3.66%). Together, they hold 13.20% of INmune Bio’s total shares outstanding.

Does Blackrock own INmune Bio?

Yes, BlackRock owns 4.51% of INmune Bio, totaling 812.9K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.17M$. In the last quarter, BlackRock increased its holdings by 572.73K shares, a 238.47% change.

Who is INmune Bio’s biggest shareholder by percentage of total assets invested?

Cvi is INmune Bio’s biggest shareholder by percentage of total assets invested, with 4.54% of its assets in 596.37K INmune Bio shares, valued at 5.26M$.

Who is the top mutual fund holder of INmune Bio shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of INmune Bio shares, with 1.91% of its total shares outstanding invested in 434.27K INmune Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools